244 related articles for article (PubMed ID: 18948273)
21. Human β-defensin 3 suppresses Porphyromonas gingivalis lipopolysaccharide-induced inflammation in RAW 264.7 cells and aortas of ApoE-deficient mice.
Bian T; Li L; Lyu J; Cui D; Lei L; Yan F
Peptides; 2016 Aug; 82():92-100. PubMed ID: 27298203
[TBL] [Abstract][Full Text] [Related]
22. Interactions between the alpha(2)-adrenergic and the prostaglandin response in the regulation of macrophage-derived tumor necrosis factor.
Ignatowski TA; Kunkel SL; Spengler RN
Clin Immunol; 2000 Jul; 96(1):44-51. PubMed ID: 10873427
[TBL] [Abstract][Full Text] [Related]
23. Sensitization of human aortic endothelial cells to lipopolysaccharide via regulation of Toll-like receptor 4 by bacterial fimbria-dependent invasion.
Yumoto H; Chou HH; Takahashi Y; Davey M; Gibson FC; Genco CA
Infect Immun; 2005 Dec; 73(12):8050-9. PubMed ID: 16299299
[TBL] [Abstract][Full Text] [Related]
24. Stimulatory effects of glucose and Porphyromonas gingivalis lipopolysaccharide on the secretion of inflammatory mediators from human macrophages.
Hung SL; Lee NG; Chang LY; Chen YT; Lai YL
J Periodontol; 2014 Jan; 85(1):140-9. PubMed ID: 23537124
[TBL] [Abstract][Full Text] [Related]
25. Porphyromonas gingivalis Infection Accelerates Atherosclerosis Mediated by Oxidative Stress and Inflammatory Responses in ApoE-/- Mice.
Xuan Y; Shi Q; Liu GJ; Luan QX; Cai Y
Clin Lab; 2017 Oct; 63(10):1627-1637. PubMed ID: 29035447
[TBL] [Abstract][Full Text] [Related]
26. Porphyromonas gingivalis lipopolysaccharide alters atherosclerotic-related gene expression in oxidized low-density-lipoprotein-induced macrophages and foam cells.
Lei L; Li H; Yan F; Li Y; Xiao Y
J Periodontal Res; 2011 Aug; 46(4):427-37. PubMed ID: 21418223
[TBL] [Abstract][Full Text] [Related]
27. Rosiglitazone impedes Porphyromonas gingivalis-accelerated atherosclerosis by downregulating the TLR/NF-κB signaling pathway in atherosclerotic mice.
Pan S; Lei L; Chen S; Li H; Yan F
Int Immunopharmacol; 2014 Dec; 23(2):701-8. PubMed ID: 25445963
[TBL] [Abstract][Full Text] [Related]
28. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
29. Toll-like receptor 4-dependent recognition of structurally different forms of chemically synthesized lipid As of Porphyromonas gingivalis.
Sawada N; Ogawa T; Asai Y; Makimura Y; Sugiyama A
Clin Exp Immunol; 2007 Jun; 148(3):529-36. PubMed ID: 17335558
[TBL] [Abstract][Full Text] [Related]
30. Celecoxib reduces brain dopaminergic neuronaldysfunction, and improves sensorimotor behavioral performance in neonatal rats exposed to systemic lipopolysaccharide.
Kaizaki A; Tien LT; Pang Y; Cai Z; Tanaka S; Numazawa S; Bhatt AJ; Fan LW
J Neuroinflammation; 2013 Apr; 10():45. PubMed ID: 23561827
[TBL] [Abstract][Full Text] [Related]
31. Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages.
Hirschfeld M; Weis JJ; Toshchakov V; Salkowski CA; Cody MJ; Ward DC; Qureshi N; Michalek SM; Vogel SN
Infect Immun; 2001 Mar; 69(3):1477-82. PubMed ID: 11179315
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications.
Chi H; Messas E; Levine RA; Graves DT; Amar S
Circulation; 2004 Sep; 110(12):1678-85. PubMed ID: 15353494
[TBL] [Abstract][Full Text] [Related]
33. Celecoxib attenuates systemic lipopolysaccharide-induced brain inflammation and white matter injury in the neonatal rats.
Fan LW; Kaizaki A; Tien LT; Pang Y; Tanaka S; Numazawa S; Bhatt AJ; Cai Z
Neuroscience; 2013 Jun; 240():27-38. PubMed ID: 23485816
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effects of tocopherols on expression of the cyclooxygenase-2 gene in RAW264.7 cells stimulated by lipopolysaccharide, tumor necrosis factor-α or Porphyromonas gingivalis fimbriae.
Murakami Y; Kawata A; Koh T; Seki Y; Tamura S; Katayama T; Fujisawa S
In Vivo; 2013; 27(4):451-8. PubMed ID: 23812214
[TBL] [Abstract][Full Text] [Related]
35. Effects of Toll-like receptor 4 on Porphyromonas gingivalis-induced bone loss in mice.
Costalonga M; Batas L; Reich BJ
J Periodontal Res; 2009 Aug; 44(4):537-42. PubMed ID: 18752565
[TBL] [Abstract][Full Text] [Related]
36. Effects of aging on endotoxin tolerance induced by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli.
Sun Y; Li H; Yang MF; Shu W; Sun MJ; Xu Y
PLoS One; 2012; 7(6):e39224. PubMed ID: 22723968
[TBL] [Abstract][Full Text] [Related]
37. Effects of micro-amounts of Porphyromonas gingivalis lipopolysaccharide on rabbit inflammatory immune response and development of atherosclerosis.
Lin G; Shi X; Chen S; Lei L; You X; Huang M; Luo L; Li Y; Zhao X; Yan F
J Periodontal Res; 2015 Jun; 50(3):356-62. PubMed ID: 25065326
[TBL] [Abstract][Full Text] [Related]
38. Nicotine and lipopolysaccharide stimulate the production of MMPs and prostaglandin E2 by hypoxia-inducible factor-1α up-regulation in human periodontal ligament cells.
Kim YS; Shin SI; Kang KL; Chung JH; Herr Y; Bae WJ; Kim EC
J Periodontal Res; 2012 Dec; 47(6):719-28. PubMed ID: 22571166
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of cyclooxygenase-2 in hematopoietic cells results in salt-sensitive hypertension.
Zhang MZ; Yao B; Wang Y; Yang S; Wang S; Fan X; Harris RC
J Clin Invest; 2015 Nov; 125(11):4281-94. PubMed ID: 26485285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
